Literature DB >> 14962196

Development and selection of marginal zone B cells.

Thiago Lopes-Carvalho1, John F Kearney.   

Abstract

It is now clear that functionally distinct subsets of mature peripheral B cells exist. Of these subsets, marginal zone (MZ) B cells in the spleen are strategically positioned at the blood-lymphoid interface and are programmed to initiate a fast and intense antibody response to blood-borne viral and bacterial agents. Their ability to respond vigorously to antigen and polyclonal activators make MZ B cells key players in the early response to pathogens in the bloodstream. The specialized functions of these innate-like lymphocytes bridge the gap between the early innate immune response and the slower adaptive antibody response, affected mainly by the more prolific follicular B cells. MZ B cells, like B1 cells, are important not only to combat infections but also in the maintenance of host homeostasis. Here we discuss some aspects of MZ B-cell selection and function in health and disease.

Entities:  

Mesh:

Year:  2004        PMID: 14962196     DOI: 10.1111/j.0105-2896.2004.0112.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  85 in total

1.  Comparative analysis of signal transduction by CD40 and the Epstein-Barr virus oncoprotein LMP1 in vivo.

Authors:  Dimitris Panagopoulos; Panayiotis Victoratos; Maria Alexiou; George Kollias; George Mosialos
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

2.  CD27+ B cells in human lymphatic organs: re-evaluating the splenic marginal zone.

Authors:  Birte Steiniger; Eva-Maria Timphus; Ralf Jacob; Peter J Barth
Journal:  Immunology       Date:  2005-12       Impact factor: 7.397

Review 3.  Innate-like B cells.

Authors:  John F Kearney
Journal:  Springer Semin Immunopathol       Date:  2005-01-12

4.  IL-10-Dependent Crosstalk between Murine Marginal Zone B Cells, Macrophages, and CD8α+ Dendritic Cells Promotes Listeria monocytogenes Infection.

Authors:  Dong Liu; Xiangyun Yin; Sam J Olyha; Manuela Sales L Nascimento; Pei Chen; Theresa White; Uthaman Gowthaman; Tingting Zhang; Jake A Gertie; Biyan Zhang; Lan Xu; Marina Yurieva; Lesley Devine; Adam Williams; Stephanie C Eisenbarth
Journal:  Immunity       Date:  2019-06-20       Impact factor: 31.745

5.  Characterisation of Peptide5 systemic administration for treating traumatic spinal cord injured rats.

Authors:  Yilin Mao; Tara Nguyen; Ryan S Tonkin; Justin G Lees; Caitlyn Warren; Simon J O'Carroll; Louise F B Nicholson; Colin R Green; Gila Moalem-Taylor; Catherine A Gorrie
Journal:  Exp Brain Res       Date:  2017-07-19       Impact factor: 1.972

6.  Apoptotic cells protect mice from autoimmune inflammation by the induction of regulatory B cells.

Authors:  M Gray; K Miles; D Salter; D Gray; J Savill
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-21       Impact factor: 11.205

7.  Notch1 engagement by Delta-like-1 promotes differentiation of B lymphocytes to antibody-secreting cells.

Authors:  Margarida Almeida Santos; Leonor Morais Sarmento; Manuel Rebelo; Ana Agua Doce; Ivan Maillard; Alexis Dumortier; Helia Neves; Freddy Radtke; Warren S Pear; Leonor Parreira; Jocelyne Demengeot
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-18       Impact factor: 11.205

8.  Natural anti-intestinal goblet cell autoantibody production from marginal zone B cells.

Authors:  Daiju Ichikawa; Masanao Asano; Susan A Shinton; Joni Brill-Dashoff; Anthony M Formica; Anna Velcich; Richard R Hardy; Kyoko Hayakawa
Journal:  J Immunol       Date:  2014-12-05       Impact factor: 5.422

9.  A p38 MAPK-MEF2C pathway regulates B-cell proliferation.

Authors:  Dustin Khiem; Jason G Cyster; John J Schwarz; Brian L Black
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-27       Impact factor: 11.205

Review 10.  Effects of acute and chronic inflammation on B-cell development and differentiation.

Authors:  Derek Cain; Motonari Kondo; Huaiyong Chen; Garnett Kelsoe
Journal:  J Invest Dermatol       Date:  2009-02       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.